Depositors claim multidrug resistance to amikacin, aztreonam, carbenicillin, cefoperazone, cefotaxime, cefoxitin, chloramphenicol, ciprofloxacin, mezlocillin, piperacillin, tetracycline, and tobramycin (see reference). ATCC could confirm antibiotic resistance only to cefoxitin and tobramycin.